期刊文献+

外周血循环肿瘤细胞、人附睾蛋白4、糖类抗原199检测在子宫内膜样腺癌筛查及分期预测中的价值

Value of peripheral blood circulating tumor cells,human epididymal protein 4 and carbohydrate antigen 199 in screening and staging prediction of endometrioid adenocarcinoma
下载PDF
导出
摘要 目的探讨术前外周血循环肿瘤细胞(CTC)、人附睾蛋白4(HE4)、糖类抗原199(CA199)单独和联合检测检查在子宫内膜样腺癌筛查及分期预测中的临床价值。方法选取2017年3月至2022年1月于中山大学肿瘤防治中心体检或就诊的293例子宫内膜正常体检者(正常组)、359例无非典型性子宫内膜增生患者(良性组)、381例子宫内膜样腺癌患者(恶性组)作为研究对象。观察3组及恶性组各分期CTC数量及HE4、CA199表达水平,以及单独和联合检测的阳性率,分析CTC、HE4、CA199单独和联合检测对子宫内膜样腺癌的诊断效能及分期的预测价值。结果3组CTC数量及HE4、CA199表达水平比较,差异有统计学意义(P<0.05);恶性组CTC数量及HE4、CA199表达水平高于良性组,差异有统计学意义(P<0.05);CTC、HE4、CA199单独和联合检测阳性率高于良性组和正常组,差异均有统计学意义(P<0.05)。恶性组各分期CTC数量及HE4表达水平差异有统计学意义(P<0.05),而各分期CA199表达水平差异无统计学意义(P>0.05)。恶性组各分期CTC、CA199、CTC+HE4、CTC+CA199、CTC+HE4+CA199检测阳性率比较,差异有统计学意义(P<0.05)。CTC+HE4+CA199检测组合对子宫内膜样腺癌诊断的受试者工作特征(ROC)曲线的曲线下面积、灵敏度、符合率、约登指数等高于其他检测组合及单项检测,CTC+HE4+CA199联合检测的曲线下面积、灵敏度和特异度分别为0.945、87.93%、92.79%。结论CTC+HE4+CA199联合检测对子宫内膜样腺癌筛查和分期预测的临床价值较高。 Objective To explore the clinical value of peripheral blood circulating tumor cells(CTC),human epididymal protein 4(HE4)and carbohydrate antigen 199(CA199)in screening and staging prediction of endometrioid adenocarcinoma.Methods From March 2017 to January 2022,293 patients with normal endometrium(normal group),359 patients without atypical endometrial hyperplasia(benign group)and 381 patients with endometrioid adenocarcinoma(malignant group)were selected as research subjects.The expression levels and positive rates of CTC,HE4 and CA199 in three groups and different stage of malignant group were observed,and the diagnostic efficacy and predictive value of CTC,HE4 and CA199 in three groups and different stage of malignant group were analyzed.Results The CTC number and expression levels of HE4 and CA199 in the three groups were significantly different(P<0.05).The expression levels of HE4 and CA199 in malignant group were significantly higher than those in benign group(P<0.05).The positive rates of CTC,HE4 and CA199 detected alone or in combination were higher than those in benign group and normal group(P<0.05).There were significant differences on the CTC number and the expression levels of HE4 in each stage of malignant group(P<0.05),but there was no significant difference on the expression levels of CA199 in each stage(P>0.05).The positive rates of CTC,CA199,CTC+HE4,CTC+CA199,CTC+HE4+CA199 in different stage of malignant group were significantly different(P<0.05).The area under receiver operating characteristic(ROC)curve,sensitivity,coincidence rate and Youden index of CTC+HE4+CA199 combined detection were higher than those of other detection combinations and single detection.The area under curve,sensitivity and specificity of CTC+HE4+CA199 combined detection were 0.945,87.93%and 92.79%respectively.Conclusion The combined detection of CTC+HE4+CA199 has high clinical value in screening and staging prediction of endometrioid adenocarcinoma.
作者 游伟强 吴小延 叶才果 王莉平 林立鹏 薛临先 肖杨 YOU Weiqiang;WU Xiaoyan;YE Caiguo;WANG Liping;LIN Lipeng;XUE Linxian;XIAO Yang(Department of Clinical Laboratory,Shenzhen Futian District Maternity and Child Healthcare Hospital,Shenzhen,Guangdong 518016,China;Department of Molecular Diagnosis,Sun Yat-sen University Cancer Center,Guangzhou,Guangdong 510060,China;Key Laboratory of Medical Molecular Diagnosis,Guangdong Province Affiliated to Guangdong Medical University,Dongguan,Guangdong 523808,China)
出处 《国际检验医学杂志》 CAS 2022年第16期1925-1929,共5页 International Journal of Laboratory Medicine
基金 国家自然科学基金项目(81572782) 广东省医学科学技术研究基金项目(A2021379)。
关键词 循环肿瘤细胞 人附睾蛋白4 糖类抗原199 子宫内膜样腺癌 筛查 分期 circulating tumor cell human epididymal protein 4 carbohydrate antigen 199 endometrioid adenocarcinoma screening staging
  • 相关文献

参考文献7

二级参考文献31

  • 1Siegel RL, Miller KD, Jemal A. Cancer statistics [ J 1. CA Cancer J Clin,2015,65 ( 1 ) :5 - 29.
  • 2Smith RA, Manassaram-Baptiste D, Brooks D, et al. Cancer screening in the United States ,2015 :A review of current American Cancer Soci- ety guidelines and current issues in cancer screening[ J]. CA Cancer J Clin,2015,65( 1 ) :30 -54.
  • 3Takeda T, Wong TF, Adachi T, et al. Guidelines for Office gynecology in Japan:Japan Society of Obstetrics and Gynecology and Japan Asso- ciation of Obstetricians and Gynecologists 2011 edition [ J 1. J Obstet Gynaecol Res,2012,38(4) :615 -631.
  • 4Breijer MC, Peeters JA, Opmeer BC, et al. Capacity of endometrial thickness measurement to diagnose endometrial carcinoma in asympto- matic postmenopausal women:a systematic review and meta-analysis [ J ]. Ultrasound Obstet Gyneco1,2012,40 ( 6 ) :621 - 629.
  • 5Dijkhuizen FP, Mol BW, Brolmann HA, et al. The accuracy of endom- etrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a recta-analysis [ J ]. Cancer, 2000,89 ( 8 ) : 1765 - 1772.
  • 6Tangjitgamol S ,Anderson BO, See HT ,et al. Management of endome- trial cancer in Asia: consensus statement from the Asian Oneology Summit 2009 [ J 1. Lancet Onco1,2009,10 ( 11 ) : 1119 - 1127.
  • 7Siegel R, Ma J,Zou Z, et al. Cancer statistics [ J ]. CA Cancer J Clin, 2014,64( 1 ) :9 -29.
  • 8Fambrini M, Sorbi F, Sisti G, et al. Endometrial carcinoma in high-risk populations:is it time to consider a screening policy[ J]. Cytopatholo- gy,2014,25(2) :71 -77.
  • 9Schmitt FC, Longatto-Filho A, Valent A, et al. Molecular techniques in cytopathology practice [ J ]. J Clin Patho1,2008,61 (3) :258 -267.
  • 10黄宝英,周伦顺,富显果,余兰,卢少玲,陈惠华,缪韵仪,刘桐宇,lulu zhang.HPV E6/E7 mRNA检测对宫颈癌筛查意义的初步评价[J].中华肿瘤防治杂志,2013,20(14):1061-1064. 被引量:34

共引文献362

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部